These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 33584673

  • 1. Extracellular Adenosine Triphosphate (eATP) and Its Metabolite, Extracellular Adenosine (eAdo), as Opposing "Yin-Yang" Regulators of Nlrp3 Inflammasome in the Trafficking of Hematopoietic Stem/Progenitor Cells.
    Ratajczak MZ, Kucia M.
    Front Immunol; 2020; 11():603942. PubMed ID: 33584673
    [Abstract] [Full Text] [Related]

  • 2. Extracellular Adenosine (eAdo) - A2B Receptor Axis Inhibits in Nlrp3 Inflammasome-dependent Manner Trafficking of Hematopoietic Stem/progenitor Cells.
    Thapa A, Abdelbaset-Ismail A, Chumak V, Adamiak M, Brzezniakiewicz-Janus K, Ratajczak J, Kucia M, Ratajczak MZ.
    Stem Cell Rev Rep; 2022 Dec; 18(8):2893-2911. PubMed ID: 35870082
    [Abstract] [Full Text] [Related]

  • 3. Novel evidence that the P2X1 purinergic receptor-Nlrp3 inflammasome axis orchestrates optimal trafficking of hematopoietic stem progenitors cells.
    Bujko K, Adamiak M, Abdelbaset-Ismail A, Thapa A, Ilowska N, Ratajczak J, Kucia M, Ratajczak MZ.
    Folia Histochem Cytobiol; 2022 Dec; 60(3):280-290. PubMed ID: 36177744
    [Abstract] [Full Text] [Related]

  • 4. Nlrp3 Inflammasome Signaling Regulates the Homing and Engraftment of Hematopoietic Stem Cells (HSPCs) by Enhancing Incorporation of CXCR4 Receptor into Membrane Lipid Rafts.
    Adamiak M, Abdel-Latif A, Bujko K, Thapa A, Anusz K, Tracz M, Brzezniakiewicz-Janus K, Ratajczak J, Kucia M, Ratajczak MZ.
    Stem Cell Rev Rep; 2020 Oct; 16(5):954-967. PubMed ID: 32661868
    [Abstract] [Full Text] [Related]

  • 5. Pannexin-1 channel "fuels" by releasing ATP from bone marrow cells a state of sterile inflammation required for optimal mobilization and homing of hematopoietic stem cells.
    Cymer M, Brzezniakiewicz-Janus K, Bujko K, Thapa A, Ratajczak J, Anusz K, Tracz M, Jackowska-Tracz A, Ratajczak MZ, Adamiak M.
    Purinergic Signal; 2020 Sep; 16(3):313-325. PubMed ID: 32533388
    [Abstract] [Full Text] [Related]

  • 6. The Nlrp3 Inflammasome Orchestrates Mobilization of Bone Marrow-Residing Stem Cells into Peripheral Blood.
    Lenkiewicz AM, Adamiak M, Thapa A, Bujko K, Pedziwiatr D, Abdel-Latif AK, Kucia M, Ratajczak J, Ratajczak MZ.
    Stem Cell Rev Rep; 2019 Jun; 15(3):391-403. PubMed ID: 31089880
    [Abstract] [Full Text] [Related]

  • 7. Novel Evidence that Purinergic Signaling - Nlrp3 Inflammasome Axis Regulates Circadian Rhythm of Hematopoietic Stem/Progenitor Cells Circulation in Peripheral Blood.
    Adamiak M, Ciechanowicz A, Skoda M, Cymer M, Tracz M, Xu B, Ratajczak MZ.
    Stem Cell Rev Rep; 2020 Apr; 16(2):335-343. PubMed ID: 31939051
    [Abstract] [Full Text] [Related]

  • 8. Danger-associated molecular pattern molecules take unexpectedly a central stage in Nlrp3 inflammasome-caspase-1-mediated trafficking of hematopoietic stem/progenitor cells.
    Thapa A, Adamiak M, Bujko K, Ratajczak J, Abdel-Latif AK, Kucia M, Ratajczak MZ.
    Leukemia; 2021 Sep; 35(9):2658-2671. PubMed ID: 33623143
    [Abstract] [Full Text] [Related]

  • 9. NLRP3 inflammasome couples purinergic signaling with activation of the complement cascade for the optimal release of cells from bone marrow.
    Ratajczak MZ, Adamiak M, Thapa A, Bujko K, Brzezniakiewicz-Janus K, Lenkiewicz AM.
    Leukemia; 2019 Apr; 33(4):815-825. PubMed ID: 30846866
    [Abstract] [Full Text] [Related]

  • 10. The Nlrp3 inflammasome - the evolving story of its positive and negative effects on hematopoiesis.
    Ratajczak MZ, Kucia M.
    Curr Opin Hematol; 2021 Jul 01; 28(4):251-261. PubMed ID: 33901136
    [Abstract] [Full Text] [Related]

  • 11. The P2X4 purinergic receptor has emerged as a potent regulator of hematopoietic stem/progenitor cell mobilization and homing-a novel view of P2X4 and P2X7 receptor interaction in orchestrating stem cell trafficking.
    Adamiak M, Bujko K, Thapa A, Pensato V, Brzezniakiewicz-Janus K, Ratajczak J, Davies DL, Ulrich H, Kucia M, Ratajczak MZ.
    Leukemia; 2022 Jan 01; 36(1):248-256. PubMed ID: 34285343
    [Abstract] [Full Text] [Related]

  • 12. Pineal Gland Hormone Melatonin Inhibits Migration of Hematopoietic Stem/Progenitor Cells (HSPCs) by Downregulating Nlrp3 Inflammasome and Upregulating Heme Oxygenase-1 (HO-1) Activity.
    Abdelbaset-Ismail A, Brzezniakiewicz-Janus K, Thapa A, Ratajczak J, Kucia M, Ratajczak MZ.
    Stem Cell Rev Rep; 2024 Jan 01; 20(1):237-246. PubMed ID: 37812364
    [Abstract] [Full Text] [Related]

  • 13. The Nlrp3 inflammasome as a "rising star" in studies of normal and malignant hematopoiesis.
    Ratajczak MZ, Bujko K, Cymer M, Thapa A, Adamiak M, Ratajczak J, Abdel-Latif AK, Kucia M.
    Leukemia; 2020 Jun 01; 34(6):1512-1523. PubMed ID: 32313108
    [Abstract] [Full Text] [Related]

  • 14. ATP-Nlrp3 Inflammasome-Complement Cascade Axis in Sterile Brain Inflammation in Psychiatric Patients and its Impact on Stem Cell Trafficking.
    Ratajczak MZ, Mack A, Bujko K, Domingues A, Pedziwiatr D, Kucia M, Ratajczak J, Ulrich H, Kucharska-Mazur J, Samochowiec J.
    Stem Cell Rev Rep; 2019 Aug 01; 15(4):497-505. PubMed ID: 31020518
    [Abstract] [Full Text] [Related]

  • 15. The Different Responsiveness of C3- and C5-deficient Murine BM Cells to Oxidative Stress Explains Why C3 Deficiency, in Contrast to C5 Deficiency, Correlates with Better Pharmacological Mobilization and Engraftment of Hematopoietic Cells.
    Konopko A, Łukomska A, Kucia M, Ratajczak MZ.
    Stem Cell Rev Rep; 2024 Sep 28. PubMed ID: 39340736
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Inhibition of CD39 and CD73 Cell Surface Ectonucleotidases by Small Molecular Inhibitors Enhances the Mobilization of Bone Marrow Residing Stem Cells by Decreasing the Extracellular Level of Adenosine.
    Adamiak M, Bujko K, Brzezniakiewicz-Janus K, Kucia M, Ratajczak J, Ratajczak MZ.
    Stem Cell Rev Rep; 2019 Dec 28; 15(6):892-899. PubMed ID: 31520298
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Heme Oxygenase 1 (HO-1) as an Inhibitor of Trafficking of Normal and Malignant Hematopoietic Stem Cells - Clinical and Translational Implications.
    Ratajczak MZ, Adamiak M, Ratajczak J, Kucia M.
    Stem Cell Rev Rep; 2021 Jun 28; 17(3):821-828. PubMed ID: 33196976
    [Abstract] [Full Text] [Related]

  • 20. The Emerging Link Between the Complement Cascade and Purinergic Signaling in Stress Hematopoiesis.
    Ratajczak MZ, Adamiak M, Kucia M, Tse W, Ratajczak J, Wiktor-Jedrzejczak W.
    Front Immunol; 2018 Jun 28; 9():1295. PubMed ID: 29922299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.